These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37957768)

  • 1. Divergent brain regional atrophy and associated fiber disruption in amnestic and non-amnestic MCI.
    Du C; Dang M; Chen K; Chen Y; Zhang Z
    Alzheimers Res Ther; 2023 Nov; 15(1):199. PubMed ID: 37957768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cingulum disruption, not gray matter atrophy, detects cognitive changes in amnestic mild cognitive impairment subtypes.
    Chang YL; Chen TF; Shih YC; Chiu MJ; Yan SH; Tseng WY
    J Alzheimers Dis; 2015; 44(1):125-38. PubMed ID: 25190630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of gray matter atrophy and cognitive assessment in differentiation of aMCI and naMCI.
    Qin R; Li M; Luo R; Ye Q; Luo C; Chen H; Qian L; Zhu X; Bai F; Zhang B; Liu R; Zhao H; Xu Y
    Appl Neuropsychol Adult; 2022; 29(1):83-89. PubMed ID: 31945304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gray matter atrophy patterns of mild cognitive impairment subtypes.
    Zhang H; Sachdev PS; Wen W; Kochan NA; Crawford JD; Brodaty H; Slavin MJ; Reppermund S; Draper B; Zhu W; Kang K; Trollor JN
    J Neurol Sci; 2012 Apr; 315(1-2):26-32. PubMed ID: 22280946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
    Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
    J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis.
    Yeung MK; Chau AK; Chiu JY; Shek JT; Leung JP; Wong TC
    Ageing Res Rev; 2022 Sep; 80():101675. PubMed ID: 35724862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cortical atrophy in subgroups of mild cognitive impairment.
    Bell-McGinty S; Lopez OL; Meltzer CC; Scanlon JM; Whyte EM; Dekosky ST; Becker JT
    Arch Neurol; 2005 Sep; 62(9):1393-7. PubMed ID: 16157746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of mild cognitive impairment among the elderly with major depressive disorder in remission.
    Yeh YC; Tsang HY; Lin PY; Kuo YT; Yen CF; Chen CC; Liu GC; Chen CS
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):923-31. PubMed ID: 22024616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects.
    Coutinho AM; Porto FH; Duran FL; Prando S; Ono CR; Feitosa EA; Spíndola L; de Oliveira MO; do Vale PH; Gomes HR; Nitrini R; Brucki SM; Buchpiguel CA
    Alzheimers Res Ther; 2015 Sep; 7(1):58. PubMed ID: 26373380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mild cognitive impairment and its subtypes as seen on diffusion tensor imaging.
    Thillainadesan S; Wen W; Zhuang L; Crawford J; Kochan N; Reppermund S; Slavin M; Trollor J; Brodaty H; Sachdev P
    Int Psychogeriatr; 2012 Sep; 24(9):1483-93. PubMed ID: 22452849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxelwise Meta-Analysis of Gray Matter Abnormalities in Mild Cognitive Impairment and Subjective Cognitive Decline Using Activation Likelihood Estimation.
    Chen S; Xu W; Xue C; Hu G; Ma W; Qi W; Dong L; Lin X; Chen J
    J Alzheimers Dis; 2020; 77(4):1495-1512. PubMed ID: 32925061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Differentiation of Amnestic Type MCI from the Non-Amnestic Types by Structural MRI.
    Csukly G; Sirály E; Fodor Z; Horváth A; Salacz P; Hidasi Z; Csibri É; Rudas G; Szabó Á
    Front Aging Neurosci; 2016; 8():52. PubMed ID: 27065855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up.
    Lee AJ; Stark JH; Hayes SM;
    J Alzheimers Dis; 2024; 100(1):357-374. PubMed ID: 38875035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared and specific dynamics of brain activity and connectivity in amnestic and nonamnestic mild cognitive impairment.
    Zhong X; Chen B; Hou L; Wang Q; Liu M; Yang M; Zhang M; Zhou H; Wu Z; Zhang S; Lin G; Ning Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2053-2065. PubMed ID: 35975454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are transversal MR images sufficient to distinguish persons with mild cognitive impairment from healthy controls?
    Mönninghoff C; Dlugaj M; Kraff O; Geisel MH; Jöckel KH; Erbel R; Weimar C; Wanke I;
    Acad Radiol; 2015 Sep; 22(9):1172-80. PubMed ID: 26162248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.
    Goñi J; Cervantes S; Arrondo G; Lamet I; Pastor P; Pastor MA
    J Alzheimers Dis; 2013; 33(4):1009-19. PubMed ID: 23064258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.